3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Recurrence
2
Osteosarcoma
2
Hematologic Neoplasms
2
Wilms Tumor
1
Sarcoma, Ewing
1
Sarcoma, Clear Cell
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Neuroblastoma
1
Neoplasms, Germ Cell and Embryonal
1
Myelodysplastic Syndromes
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphoid
1
Leukemia, Large Granular Lymphocytic
1
Leukemia, B-Cell
1
Leukemia
1
Hodgkin Disease
1
Hepatoblastoma
1
Desmoplastic Small Round Cell Tumor
1
Carcinoma
1
Burkitt Lymphoma
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Bevacizumab
13
atezolizumab
9
Specimen Handling
9
durvalumab
8
Nivolumab
7
Magnetic Resonance Spectroscopy
7
tremelimumab
6
lenvatinib
6
cabozantinib
4
Sorafenib
4
tislelizumab
3
donafenib
3
X-Rays
3
Surgical Procedures, Operative
3
Oxaliplatin
3
Ipilimumab
3
Immunotherapy
3
Fluorouracil
3
ulixertinib
2
sintilimab
2
sapanisertib
2
relatlimab
2
pembrolizumab
2
camrelizumab
2
apatinib
2
Leucovorin
2
Irinotecan
2
Fluorodeoxyglucose F18
2
Doxorubicin
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Hepatocellular
×
Mesna
×
30 days
×
Clear all
No trials found.